Flu Crazy 200 - The Largest Pharmaceutical Companies in the world, by size

Flu Crazy 200 - The Largest Pharmaceutical Companies in the world, by size

Johnson    & Johnson
Pfizer Inc
Roche Holding    Ltd.
Novartis AG
Merck &    Co.,
GlaxoSmithKline    plc
Sanofi SA
Abbott Laboratories   
Novo-Nordisk A/S   
Bayer AG   
AstraZeneca plc   
Bristol-Myers Squibb Company
Amgen,Inc.   
Eli Lilly   
Teva Pharmaceutical Industries
Gilead    Sciences,Inc.
Takeda Pharmaceutical Company
Celgene    Corporation
Allergan,Inc
McKesson Corporation   
Astellas Pharma    Inc.
Shire PLC   
CSL Ltd.   
Fresenius SE
Alexion    Pharmaceuticals, Inc.
Valeant    Pharmaceuticals    International,
Cardinal Health, Inc.
Daiichi    Sankyo    Company
Eisai Co.,Ltd.
Sun Pharmaceutical Industries
Regeneron Pharmaceuticals, Inc.
AmerisourceBergen Corporation   
Mylan Inc
Chugai Pharmaceutical Co
Perrigo    Company   
Vertex Pharmaceuticals Inc
Forest Laboratories,Inc
Elan Corporation plc
Life Technologies Corporation
Herbalife Ltd.   
Mitsubishi Tanabe Pharma
UCB S.A.
Watson Pharmaceuticals,    Inc.
Taisho Pharmaceutical Holdings
Merck KGaA
Ono Pharmaceutical Co
Aspen Pharmacare Holdings
Kyowa Hakko Kirin
Grifols    S.A.   
Hospira,Inc   
Yunnan Baiyao Group
Dr. Reddy's Laboratories
Shanghai Pharmaceuticals Holding
Actelion Ltd.   
Jiangsu    Hengrui    Medicine
Shionogi & Co
Cipla Ltd
Kangmei    Pharmaceutical    Co.,
IDEXX    Laboratories,    Inc.
Shandong    Weigao    Group
Lupin    Limited   
Hisamitsu    Pharmaceutical    Co.,
Dainippon    Sumitomo    Pharma
Endo    Pharmaceuticals    Holdings
Warner    Chilcott    PLC
Galenica    AG   
H.    Lundbeck    A/S
BioMarin    Pharmaceutical    Inc.
PT    Kalbe    Farma
GlaxoSmithKline    Pharmaceuticals    Ltd
Dabur    India    Ltd
Santen    Pharmaceutical    Co.,
Sichuan    Kelun    Pharmaceutical
Ranbaxy    Laboratories    Ltd.
Tianjin    Tasly    Pharmaceutical
Chr.    Hansen    Holding
Celesio    AG   
Shenzhen    Hepalink    Pharmaceutical
Richter    Gedeon    Nyrt.
Beijing    Tongrentang    Co.,
Orion    Oyj   
Salix    Pharmaceuticals    Ltd
Medipal    Holdings    Corp
Shanghai    Fosun    Pharmaceutical
Suzuken    Co.,    Ltd.
Cadila    Healthcare   
Jilin    Aodong    Medicine
China    Resources    Sanjiu
A    Meda    AB
Jazz    Pharmaceuticals    PLC.
Techne    Corporation   
United    Therapeutics    Corporation
Amylin    Pharmaceuticals,    Inc.
Hualan    Biological    Engineering
ARIAD    Pharmaceuticals,    Inc.
ONYX    Pharmaceuticals,    Inc.
Krka,    tovarna    zdravil,
Harbin    Pharmaceutical    Group
Zhejiang    Hisun    Pharmaceutical
Questcor    Pharmaceuticals,    Inc.
Shijiazhuang    Yiling    Pharmaceutical
Seattle    Genetics,    Inc.
Qualicorp    SA
Ipsen    SA   
Hikma    Pharmaceuticals    plc
Miraca    Holdings    Inc.
Fleury    S.A.   
Alkermes    Public    Limited
GlaxoSmithKline    Consumer    Healthcare
Kobayashi    Pharmaceutical    Co.,
Denki    Kagaku    Kogyo
Medicis    Pharmaceutical    Corporation
ViroPharma,    Inc.  
Genomma    Lab    Internacional
Tsumura    &    Co.
Vivus,    Inc.    United
Divi's    Laboratories    Ltd.
Nippon    Kayaku    Company
Huadong    Medicine    Co.,
Beijing    SL    Pharmaceutical
Gansu    Yasheng    Industrial
BTG    plc    United
Guilin    Jiqi    Pharmaceutical
Zhejiang    Medicine    Co.,
STADA    Arzneimittel    AG
Pharmacyclics,    Inc.   
Sawai    Pharmaceutical    Co.,
Shenzhen    Salubris    Pharmaceuticals
S&P    Pharmaceutical    Co
Piramal    Healthcare    Limited
Glenmark    Pharmaceuticals    Ltd
Theravance,    Inc.  
Tieling    Newcity    Investment
Zhangzhou    Pientzehuang    Pharmaceutical
Taro    Pharmaceutical    Industries
Human    Genome    Sciences,
Recordati    S.p.A.   
Impax    Laboratories    Inc.
Wuhan    Humanwell    Healthcare
Financiere    de    Tubize
Chongqing    Zhifei    Biological
DiaSorin    S.p.A.   
Beijing    Double-Crane    Pharmaceutical
Opko    Health    Inc.
Inner    Mongolia    Yili
Kyorin    Holdings    Inc
Ironwood    Pharmaceuticals    Inc.
China    Shineway    Pharmaceutical
Almirall    S.A.   
Amarin    Corporation    plc
Adcock    Ingram    Holdings
Corporativo    Fragua,    S.A.
Rohto    Pharmaceutical    Co.,
Guangzhou    Pharmaceutical    Co
Mochida    Pharmaceutical    Co.,
Toho    Holdings    Co.,
Par    Pharmaceutical    Companies,
Halozyme    Therapeutics,    Inc.
Kaken    Pharmaceutical    Co.,
Tibet    Urban  Development
Virbac    SA
Jiangxi    Jiangzhong  Pharmaceutical
Tempo    Scan    Pacific,
Wockhardt    Ltd.   
China    Medical    System
Guilin    Sanjin    Pharmaceutical
Scinopharm    Taiwan,    Ltd.
Shanghai    RAAS    Blood Products Co
BB    Biotech    AG
Sartorius    Stedim    Biotech
Akorn,    Inc.    United
Xizang    Haisco    Pharmaceutical
Guizhou    Bailing    Group
Kissei    Pharmaceutical    Co.,
Tibet    Cheezheng Tibet Medicine Co, Inc.
The Medicines    Company
AstraZeneca    Pharma   
Zhejiang    Huahai    Pharmaceutical
Green    Cross    Corp
Jiangsu    Wuzhong    Industrial

Sales of vaccines drop for pharmaceutical giant Novartis, following end of bogus flu pandemic

According to BusinessWeek, fourth quarter net profit for Novartis AG dropped by 2 percent due to a decline in sales of its vaccines.

"Swiss pharmaceutical company Novartis AG (NVS) says fourth quarter net profit slipped by 2 percent to $2.32 billion due to a drop in demand for its vaccines, although total sales grew by 10 percent to $14.19 billion.

[According to BusinessWeek] the company says profit was hurt by a decline in sales of influenza vaccine following the end of the flu pandemic, pushing its vaccine division's sales 74 percent lower to $361 million."

This is a bit odd. We are constantly told that flu vaccine sales don't amount to a hill of beans. Thus, there is no possibility for a conflict of interest when it comes to flu vaccine recommendations by the CDC and other health bodies (like the World Health Organization - WHO). However, there is clearly profit to be made and, despite protestations to the contrary, the threat of conflict of interest remains.

The Washington Post had earlier reported on some of the more dubious conflicts of interest at WHO, but the root problems remain -- experts at WHO with financial ties to the pharmaceutical industry, hidden by a veil of anonymity. Novartis has not been tied to these particular scandals, but they clearly profit by flu hysteria.

See: http://www.washingtonpost.com/wp-dyn/content/article/2010/06/04/AR2010060403034.html

The global swine flu pandemic charged up sales of vaccines, despite the fact that fewer people died from swine flu, then die from the regular, seasonal flu. Now that the "pandemic" has been declared over (see: WHO. http://www.hhs.gov/news/press/2010pres/08/20100810b.html), sales are dipping.

http://www.businessweek.com/ap/financialnews/D9L0IB9G1.htm